Enhancement of the thermal response of murine tumour and normal tissues by a streptococcal preparation, OK-432 (Picibanil)

References

• Dickson J. A., Shah S. A. Hyperthermia: the immune response and tumor metastasis. National Cancer Institute Monographs 1982; 61: 183–192
   PubMedGoogle Scholar
• Dickson J. A., Shah S. A. Immunological aspects of hyperthermia. Hyperthermia in Cancer Therapy, F. K. Strom. G. K. Hall, Boston, MA 1983; 487–543
   Google Scholar
• Fujii M., Abo T., Kumagai K. Cytokines produced by blood mononuclear cells stimulated with the streptococcal preparation OK-432: effect on production by supplementing the medium with xenogenic serum. Cancer Immunology and Immunotherapy 1988; 27: 97–102
   PubMed Web of Science ®Google Scholar
• Fukui H., Reynolds C. V., Lenz B., Schneider M., Talmadge J. E. Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosis. Cancer Immunology and Immunotherapy 1989; 29: 1–6
   PubMed Web of Science ®Google Scholar
• Ishida N., Hoshino T. a, Distribution and metabolism of OK-432. A Streptococcal Preparation as a Potent Biological Response Modifier, N. Ishida, T. Hoshino. Excerpta Medica, Tokyo 1985; 6–7
   Google Scholar
• Ishida N., Hoshino T. b, Antitumor effect of combined administration with other agents. A Streptococcal Preparation as a Potent Biological Response Modifier, N. Ishida, T. Hoshino. Excerpta Medica, Tokyo 1985; 12–13
   Google Scholar
• Ishida N., Suzuki S., Saito M., Sugawara Y., Ishida N. Augmentation of interleukin 1 and interleukin 2 production by OK-432. International Journal of Immunopharmacology 1985; 7: 263–270
   PubMedGoogle Scholar
• Ishii Y., Yamaoka H., Toh K., Kikuchi K. Inhibition of tumor growth in vivo and in vitro by macrophages from rats treated with a streptococcal preparation, OK-432. Gann 1976; 67: 115–119
   PubMedGoogle Scholar
• Kawaguchi T., Suematsu H., Koizumi M., Mitsui H., Suzuki S., Matsuno T., Ogawa H., Nomoto K. Activation of macrophage function by intraperitoneal administration of the streptococcal antitumor agent OK-432. Immunopharmacology 1983; 6: 177–189
   PubMed Web of Science ®Google Scholar
• Kimura I., Ohnoshi Y., Yasuhara S., Watanabe T., Sugiyama M., Kiraki K. Studies on the host-mediated action of the streptococcal preparation, OK-432, in cancer chemotherapy. Acta Medica Okayama 1974; 28: 423–431
   PubMed Web of Science ®Google Scholar
• Komatsu K., Nakamura W. Combined effect of CIS-DDP, OK-432 and systemic hyperthermia on ascites tumor in mice. Abstracts of 5th International Symposium on Hyperthermic Oncology, KyotoJapan, 1988, 308
   Google Scholar
• Mondovi B., Santoro A. S., Strom R., Faiola F., Fanelli A. R. Increased immunogenicity of Ehrlich ascites cells after heat treatment. Cancer 1972; 30: 885–888
   PubMed Web of Science ®Google Scholar
• Mukai M., Ando K., Koike S., Nagao K. Effect of combination therapy of radiation and local administration of OK-432 on a murine fibrosarcoma. International Journal of Radiation Oncology, Biology, Physics 1989; 17: 125–130
   PubMedGoogle Scholar
• Okamoto H., Shoin S., Koshimura S., Shimizu R. Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci. Japanese Journal of Microbiology 1967; 11: 323–336
   PubMedGoogle Scholar
• Oshimi K., Wakasugi H., Seki H., Kano S. a, Streptococcal preparation OK-432 augments cytotoxic activity against an erythroleukemic cell line in humans. Cancer Immunology and Immunotherapy 1980; 9: 187–192
   Web of Science ®Google Scholar
• Oshimi K., Kano S., Takaku F., Okumura K. b, Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432. Journal of the National Cancer Institute 1980; 65: 1265–1269
   PubMedGoogle Scholar
• Ryoyama C, Ryoyama K. Effects of injection routes of growing tumors of PSK or OK-432 on antiproliferative activity of mouse serum. Cancer Immunology and Immunotherapy 1989; 28: 101–106
   PubMed Web of Science ®Google Scholar
• Sakurai Y., Tsukagoshi S., Satoh H., Akiba T., Suzuki S., Takagaki Y. Tumorinhibitory effect of a streptococcal preparation (NCS-B116209). Cancer Chemotherapy Report 1972; 56: 9–17
   PubMedGoogle Scholar
• Tomasovic S. P., Barta M., Klostergaard J. Temporal dependence of hyperthermic augmentation of macrophage-TNF production and tumor cell-TNF sensitization. International Journal of Hyperthermia 1989; 5: 625–639
   PubMed Web of Science ®Google Scholar
• Urano M., Kahn J. Differential kinetics of thermal resistance (thermotolerance) between murine normal and tumor tissues. International Journal of Radiation Oncology, Biology, Physics 1986; 12: 89–93
   PubMed Web of Science ®Google Scholar
• Urano M., Nesumi N., Ando K., Koike S., Ohnuma N. Repair of potentially lethal radiation damage in acute and chronically hypoxic tumor cells. in vivo. Radiology 1976; 118: 447–451
   Google Scholar
• Urano M., Suit H. D., Dunn P., Lansdale T., Sedlacek R. Enhancement of the thermal response of animal tumors by. C. parvum. Cancer Research 1979; 39: 3454–3457
   PubMedGoogle Scholar
• Urano M., Rice L., Epstein R., Suit H. D., Chu A. M. Effect of whole-body hyperthermia on cell survival, metastasis frequency and host immunity in moderately and weakly immunogenic murine tumors. Cancer Research 1983; 43: 1039–1043
   PubMed Web of Science ®Google Scholar
• Urano M., Overgaard M., Suit H. D., Dunn P., Sedlacek R. Enhancement by Corynebacterium parvum of the normal and tumor tissue response to hyperthermia. Cancer Research 1978; 38: 862–864
   PubMed Web of Science ®Google Scholar
• Urano M. Tumor response to hyperthermia. Hyperthermia and Oncology, Vol. 1, M. Urano, E. Douple. VSP, The Netherlands 1988; 161–200
   Google Scholar
• Yamamoto A., Nagamuta M., Usami H., Sugawara Y., Watanabe N., Niitsu Y., Urushizaki I. Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation. Immunopharmacology 1986; 11: 79–86
   PubMed Web of Science ®Google Scholar